Tissue transglutaminase: A multifunctional and multisite regulator in health and disease

Z Yao, Y Fan, L Lin, RE Kellems… - Physiological …, 2024 - journals.physiology.org
Tissue transglutaminase (TG2) is a widely distributed multifunctional protein involved in a
broad range of cellular and metabolic functions carried out in a variety of cellular …

Single-cell migration in complex microenvironments: mechanics and signaling dynamics

M Mak, F Spill, RD Kamm… - Journal of …, 2016 - asmedigitalcollection.asme.org
Cells are highly dynamic and mechanical automata powered by molecular motors that
respond to external cues. Intracellular signaling pathways, either chemical or mechanical …

[HTML][HTML] Transglutaminase 2 in human diseases

Z Szondy, I Korponay-Szabó, R Király, Z Sarang… - BioMedicine, 2017 - ncbi.nlm.nih.gov
Abstract Transglutaminase 2 (TG2) is an inducible transamidating acyltransferase that
catalyzes Ca (2+)-dependent protein modifications. In addition to being an enzyme, TG2 …

Thiol–Disulfide exchange reactions in the mammalian extracellular environment

MC Yi, C Khosla - Annual review of chemical and biomolecular …, 2016 - annualreviews.org
Disulfide bonds represent versatile posttranslational modifications whose roles encompass
the structure, catalysis, and regulation of protein function. Due to the oxidizing nature of the …

Tissue transglutaminase constitutively activates HIF-1α promoter and nuclear factor-κB via a non-canonical pathway

S Kumar, K Mehta - PloS one, 2012 - journals.plos.org
Constitutive activation of nuclear factor kappa B (NF-κB) has been linked with
carcinogenesis and cancer progression, including metastasis, chemoresistance, and …

Influencing COX-2 activity by COX related pathways in inflammation and cancer

T Yu, X Lao, H Zheng - Mini reviews in medicinal chemistry, 2016 - ingentaconnect.com
Cancer is a major cause of death worldwide despite significant advances in surgery and
biology. Several recent studies have suggested that there is a close connection between …

[HTML][HTML] Transglutaminase 2 in cancer

L Huang, AM Xu, W Liu - American journal of cancer research, 2015 - ncbi.nlm.nih.gov
The significant influence of tumor microenvironment on malignant cells has been
investigated with enthusiasm in this era of targeted therapy. Transglutaminase 2 (TG2, EC …

The role of tissue transglutaminase in cancer cell initiation, survival and progression

C Tabolacci, A De Martino, C Mischiati, G Feriotto… - Medical …, 2019 - mdpi.com
Tissue transglutaminase (transglutaminase type 2; TG2) is the most ubiquitously expressed
member of the transglutaminase family (EC 2.3. 2.13) that catalyzes specific post …

Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma

MM Caffarel, N Coleman - The Journal of pathology, 2014 - Wiley Online Library
Cervical carcinoma is the second most common cause of cancer deaths in women
worldwide. Treatments have not changed for decades and survival rates for advanced …

[HTML][HTML] Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition

ML Fisher, G Adhikary, W Xu, C Kerr, JW Keillor… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Type II transglutaminase (TG2) is a multifunctional protein that has recently been implicated
as having a role in ECS cell survival. In the present study we investigate the role of TG2 in …